Instylla, Inc. announced premarket approval (PMA) from the FDA for the company’s flagship Embrace hydrogel embolic system.

Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided ...

HistoSonics, the developer of the Edison histotripsy system and histotripsy therapy platform, announced a management-led majority ...

The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ...

Access to better care, rapid intervention, and standardized procedures with predictable outcomes is critical for treating ...

AngioDynamics, Inc. announced enrollment of the first patient in the AMBITION BTK study of the Auryon atherectomy system.

Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, announced ...

Inari Medical, now part of Stryker, announced the launch of its next-generation InThrill thrombectomy system. According to ...

Advanced mechanical design to address both subacute, organized thrombus and more dense, fibrotic tissue; devices with a low ...

Embolx, a developer of microcatheters for targeted embolization procedures, announced the market release of its ...

Cook Medical announced the launch of its Interventional MRI (iMRI) division, which will collaborate with physicians, ...

A discussion on pathophysiology, patient workup, gaps in data and disease-specific tools, and postprocedural follow-up and ...